Outcome (all reported values are discounted) | Pioglitazone | Placebo | Difference (PIO – PLA) |
---|---|---|---|
Clinical outcomes | Â | Â | Â |
Life expectancy (years) | 10.044 (0.140) | 9.871 (0.139) | 0.172 |
Quality-adjusted life expectancy (QALYs) | 7.543 (0.102) | 7.422 (0.102) | 0.120 |
Cost outcomes | Â | Â | Â |
Total direct costs (€) | 105,433 (2,650) | 103,834 (2,618) | 1,599 |
Incremental cost-effectiveness based on life expectancy | €9,281 per life year gained |  |  |
Incremental cost-effectiveness based on quality-adjusted life expectancy | €13,294 per QALY gained |  |  |